You just read:

Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'

News provided by

Asterias Biotherapeutics, Inc.

Apr 26, 2017, 07:00 ET